1. HOME
2. Research Insight
3. EssilorLuxottica (France) and Alcon (Switzerland) are Leading Players in the Ophthalmic Equipment Market

The global Ophthalmic Equipment Market is projected to reach USD 88.5 billion by 2029 from USD 66.2 billion in 2023, growing at a CAGR of 4.9% during the forecast period. The global population ages and awareness of eye health soars, the prevalence of age-related macular degeneration, cataracts, and glaucoma is steadily rising. This surge in demand for diagnosis and treatment fuels a dynamic ophthalmic equipment market, brimming with cutting-edge solutions. Specialized tools like fundus cameras, optical coherence tomography (OCT) scanners, and phaco emulsifiers for cataract surgery are witnessing significant growth, driven by the need for precise diagnoses and minimally invasive procedures. Innovation remains the lifeblood of this market. Breakthroughs like AI-powered diagnostics, capable of detecting subtle abnormalities with remarkable accuracy, hold immense promise for improved patient outcomes and earlier intervention. Minimally invasive surgical tools, boasting faster recovery times and reduced complications, are revolutionizing surgical practices. Even the horizon of gene therapy beckons, offering the potential to one day reverse vision loss. These advancements not only improve patient care but also create entirely new market segments, attracting significant investments and propelling the industry forward.

The prominent players in the Ophthalmic Equipment Market include Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson & Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc. (US), EssilorLuxottica (France), Canon Inc. (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Ziemer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), BVI (US), DORC (Netherlands), CORZA Medical (US), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).

To know about the assumptions considered for the study download the pdf brochure

EssilorLuxottica, is a leader in the Ophthalmic Equipment Market. A global eyecare powerhouse, EssilorLuxottica boasts an unmatched portfolio. Diverse solutions, spanning lenses to lasers, cater to individual needs while their extensive reach and unwavering innovation keep them at the forefront of eye health. Their comprehensive range, built on decades of expertise and global presence, empowers individuals to see clearly, wherever they are. From correcting nearsightedness to peering into the future with AI, EssilorLuxottica's eye care symphony plays across continents. Their diverse solutions, born from a rich history and unwavering innovation, ensure everyone can see the world in vibrant focus. EssilorLuxottica has strategically acquired leading companies like GrandVision and HAL in recent years, solidifying their position in the retail and surgical equipment segments respectively. These partnerships not only expand their product offerings but also allow them to leverage diverse expertise and resources.

Alcon (Switzerland), Inc. was placed in second position in this market. Alcon reigns in cataract and glaucoma surgery, with VerifEye and Acrysoft IOLs leading the charge. Their relentless pursuit of precise, minimally invasive tools secures their reputation for innovation and quality. From routine checkups with fundus cameras to in-depth retinal views with advanced OCTs, Alcon's diagnostic arsenal empowers eye care across every step. With a global reach spanning 70 countries, they tailor solutions to diverse needs, ensuring everyone sees the future clearly. Biocompatible implants, AI-powered diagnostics – Alcon's R&D pushes the boundaries of what's possible. Their commitment to innovation isn't just shaping the present; it's illuminating the future of eye care. Cataracts and glaucoma tremble before VerifEye and Acrysoft, testaments to Alcon's surgical prowess. But their vision extends beyond the operating room. From fundus cameras for first glimpses to OCTs unveiling retinal mysteries, they equip every step of the eye care journey. And with a global network spanning continents, Alcon ensures everyone, everywhere, sees a brighter future.

Johnson & Johnson (US) held the number three position in the Ophthalmic Equipment Market. It has TECNIS IOLs and Catalys phaco emulsifiers leading the charge. Their relentless pursuit of minimally invasive, tech-driven solutions secures their throne as a leader. From pre-op checks with autorefractors to delicate vitreoretinal procedures, J&J's arsenal empowers eye care across every step. Their global reach, spanning 150+ countries, ensures tailored solutions reach diverse needs, leaving no vision behind. Femtosecond lasers and gene therapy – J&J's R&D cracks open the future of ophthalmology. Beyond cataract dominance, their diverse equipment and relentless innovation paint a brighter picture for eye care worldwide. Cataracts tremble before TECNIS, and Catalyst orchestrates minimally invasive symphonies in the operating room. But J&J's vision extends far beyond. From autorefractors' first glimpses to vitreoretinal devices peering into the eye's secrets, they equip every stage of the journey.

Related Reports:

Ophthalmic Equipment Market by Devices (Surgical: Vitreoretinal, IOLs, OVDs, Contact Lens, RGP Lens, Backflush; Diagnostic & Monitoring: OCT, Autorefractor, Keratometer, Tonometer, Ophthalmoscope, OVD), End User, Buying Criteria - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]